Shudan Yao1, Lihang Wang1, Qiling Chen1, Tingsheng Lu1, Xingwei Pu1, Chunshan Luo2. 1. MM. Department of Spine Surgery - Guizhou Orthopedic Hospital - Guizhou Province, China. 2. PhD. Department of Spine Surgery - Guizhou Orthopedic Hospital - Guizhou Province, China.
Abstract
PURPOSE: To probe the mechanism of mild hypothermia combined with rutin in the treatment of spinal cord injury (SCI). METHODS: Thirty rats were randomized into the following groups: control, sham, model, mild hypothermia (MH), and mild hypothermia plus rutin (MH+Rutin). We used modified Allen's method to injure the spinal cord (T10) in rats, and then treated it with MH or/and rutin immediately. BBB scores were performed on all rats. We used HE staining for observing the injured spinal cord tissue; ELISA for assaying TNF-α, IL-1β, IL-8, Myeloperoxidase (MPO), and Malondialdehyde (MDA) contents; Dihydroethidium (DHE) for measuring the reactive oxygen species (ROS) content; flow cytometry for detecting apoptosis; and both RT-qPCR and Western blot for determining the expression levels of TGF-β/Smad pathway related proteins (TGF-β, Smad2, and Smad3). RESULTS: In comparison with model group, the BBB score of MH increased to a certain extent and MH+Rutin group increased more than MH group (p < 0.05). After treatment with MH and MH+Rutin, the inflammatory infiltration diminished. MH and MH+Rutin tellingly dwindled TNF-β, MDA and ROS contents (p < 0.01), and minified spinal cord cell apoptosis. MH and MH+Rutin could patently diminished TGF-β1, Smad2, and Smad3 expression (p < 0.01). CONCLUSIONS: MH+Rutin can suppress the activation of TGF-β/Smad pathway, hence repressing the cellular inflammatory response after SCI.
PURPOSE: To probe the mechanism of mild hypothermia combined with rutin in the treatment of spinal cord injury (SCI). METHODS: Thirty rats were randomized into the following groups: control, sham, model, mild hypothermia (MH), and mild hypothermia plus rutin (MH+Rutin). We used modified Allen's method to injure the spinal cord (T10) in rats, and then treated it with MH or/and rutin immediately. BBB scores were performed on all rats. We used HE staining for observing the injured spinal cord tissue; ELISA for assaying TNF-α, IL-1β, IL-8, Myeloperoxidase (MPO), and Malondialdehyde (MDA) contents; Dihydroethidium (DHE) for measuring the reactive oxygen species (ROS) content; flow cytometry for detecting apoptosis; and both RT-qPCR and Western blot for determining the expression levels of TGF-β/Smad pathway related proteins (TGF-β, Smad2, and Smad3). RESULTS: In comparison with model group, the BBB score of MH increased to a certain extent and MH+Rutin group increased more than MH group (p < 0.05). After treatment with MH and MH+Rutin, the inflammatory infiltration diminished. MH and MH+Rutin tellingly dwindled TNF-β, MDA and ROS contents (p < 0.01), and minified spinal cord cell apoptosis. MH and MH+Rutin could patently diminished TGF-β1, Smad2, and Smad3 expression (p < 0.01). CONCLUSIONS:MH+Rutin can suppress the activation of TGF-β/Smad pathway, hence repressing the cellular inflammatory response after SCI.
Spinal cord injury (SCI), a devastating illness, is principally induced by falls and
road traffic accidents, and can have a profound impact on the patient’s health and
emotions, as well as a huge economic burden for the family and the entire
society1. In addition to the direct
consequence of the loss of motor, sensory, and autonomic nervous system function,
the secondary protrusions at the injured site can aggravate the injury. Subsequent
problems include muscular atrophy, chronic pain, urinary tract infections, and
pressure sores. Statistical data manifested that 930.000 SCI patients were newly
added in 2016. Thus, SCI is mountingly regarded as a focus impacting global
health2. The damage associate with SCI is
classified into two stages: immediate and irreversible main damage, and the
secondary damage, caused by diverse chemical substances, embracing free radicals and
excitatory amino acids, which are the pivotal factors of motor and sensory
defects3.Systemic hypothermia has been broadly applied in the field of SCI research. In
clinical trials, particularly in remedying neonatal asphyxia, cardiac arrest, and
acute SCI, surface cooling can be carried out by utilizing ice blankets, cooling
bags or soaking in an ice bath, so as to realize systemic cryotherapy4. Clinical evidence has illuminated that the
hypothermia in patients with severe acute SCI does not dramatically escalate the
risk of complications5,6. The study outcomes displayed that athletes have attained a
good prognosis by applying hypothermia treatment early after severe cervical
SCI7. Research has expounded that
hypothermia can reduce secondary pathological mechanisms, such as apoptosis, edema,
oxidative stress, excitotoxicity, inflammation, etc.4.Flavonoid is the main dietary component of plant-based food and is bioactive
polyphenols with anti-inflammatory and antioxidant effects. Bone health is related
to the consumption of flavonoids, whose intake increases bone density (BMD) in the
neck and spine, as well as decreases bone resorption in perimenopausal women8. Supposedly, flavonoids reduce low-level
inflammation and oxidative stress as markers of protection against bone loss. In
addition, flavonoids are believed to promote the upregulation of osteoblast activity
signaling pathways9. Rutin is a
flavonolid-type polyphenol, which is composed of the flavonolquercetin and the
disacchariderutinose. Rutin has anti-tumor, antibacterial and other biological
effects, mainly related to antioxidant and anti-inflammatory activities. Rutin was
showed to promote ossification in bone cells as well as to possess punctuate
proliferative activity with minimal influence to cell cycle distribution.Hereby, this investigation was aimed at delving into the treatment effect and related
mechanisms of mild hypothermia plus rutin on SCI, so as to offering theoretical
basis and potential therapy for remedying SCI.
Methods
The animal experiment research protocol was approved by the Ethics Committee of
Guizhou Orthopedic Hospital and performed in accordance with the Guidelines
for the Care and Use of Experimental Animals. The experiment was also
approved by the Ethics Committee of the Guizhou Orthopedic Hospital (NO.t-a309).
Construction and processing of spinal cordinjury model
The ratspinal cord injury model provides an important mammalian model for
evaluating treatment strategies and understanding the pathological basis of
spinal cord injury. We anesthetized the rats via intraperitoneal injection of
10% chloral hydrate, shaved their back hair, and disinfected the skin with
iodophor, subsequently cutting the skin longitudinally with the T11 thoracic
spine as the midpoint, about 3 to 4 cm. After incising the skin, we removed the
muscles on the T10 and T11 thoracic vertebrae, and exposed the T10 and T11
lamina. Then, we used small scissors and hemostatic forceps to carefully remove
the T10 and T11 lamina, exposed the spinal cord, and gently sticked the
self-made pad on the exposed epidural surface. Subsequently, we used a 12 g
percussion stick, a self-made percussion device, to hit the gasket vertically,
from a 7 mm height free fall from the graduated sleeve10-11. By using this
method, ruptured middle spinal cord, intramedullary hemorrhage, and reperfusion
were observed, which caused acute SCI. Complete spinal cord injury causes
permanent paralysis of the hindlimbs and a corresponding impairment of the
sensory and autonomic system functions. The gasket was stressed and damaged the
spinal cord. Ultimately, the muscles, fascia, and skin were sutured, and the
wound was disinfected again.
Grouping
Thirty healthy adult female SD rats, weighing 220–250 g (Hunan SJA Laboratory
Animal Co.Ltd), were divided into the following groups: control, sham, model,
mild hypothermia (MH), and mild hypothermia + rutin (MH+Rutin), with 6 rats in
each group. Subsequently, we supplemented some BBB scores of the mice in the MH
(total n = 15) and the MH+Rutin groups (total n = 15). Among them, control group
was composed by normal reared rats; sham group, by rats with simple operation,
but not hitting spinal cord; and model group, by SCI model rats. In MH group,
after modelling, we placed the rats on an ice blanket to cool down. We
maintained their rectal temperature at 28–32 ºC lasting 4 h, and then rewarmed
them. In another hand, in MH+Rutin group, after modelling, we also placed the
rats on an ice blanket to cool down, treating them, afterwards, with
intraperitoneal injection of rutin (30 mg/kg, once daily, for 3 days; Solarbio),
and controlling their rectal temperature at 28–32 ºC lasting 4 h; then, we
rewarmed the rats. BBB scores were performed on all rats at 24 h, 48 h, 72 h, 7
days, and 30 days subsequent to surgery. Rats in each group were sacrificed 72 h
or 7 days later, and spinal cord tissues were taken for subsequent studies.
HE staining
The tissues were taken and irrigated with running water for several hours. Then,
they were dehydrated by 70, 80, and 90% ethanol solutions, and placed into a
mixture of pure alcohol and xylene (1:1), lasting 15 min. Subsequently, the
tissues were dewaxed utilizing xylene I, lasting 15 min, and xylene II, lasting
the same amount of time (until transparent). We added the mixture of xylene and
paraffin (1:1) for 15 min, then paraffins I and II for 50–60 min each. Next,
paraffin embedding and slicing were conducted. The paraffin slices were baked,
then dewaxed and hydrated. We placed the slices into the distilled water, and
then into hematoxylin aqueous solution (ZLI-9610; ZSGB-Bio) for staining,
lasting 3 min. Later, the slices were differentiated into a hydrochloric acid
ethanol solution, lasting 15 s. Plus, they were irrigated with water; backed to
blue, using Scott Blue Solution (G1865; Solarbio), for 15 s; rinsed with running
water; stained with eosin lasting solution (G1100; Solarbio), for 3 min; and
rinsed with running water. Then, dehydration, transparency, and sealing,
microscopic examination were implemented.
Detection of inflammatory factors
We isolated the rat serum from each group. Later, samples and enzymes were added,
and incubation, mixing, washing, color development and termination were
conducted, in sequence, according to the ELISA kit’s instructions for detecting
TNF-a (m1002859, enzyme-linked), IL-1β (m1003549, enzyme-linked), IL-8
(m1037351, enzyme-linked), and Myeloperoxidase (MPO) (m1003250, enzyme-linked).
The OD value was tested at 450 nm, by using multifunctional microplate reader
(S/N502000011, TECAN).We calculated the linear regression equation of the
standard curve with the concentration of the standard substance and the OD
value, substituting the OD value of the sample into the equation, to calculate
the sample concentration, and multiplying it by the dilution factor, to obtain
the actual concentration of the sample.
Detection of ROS and MDA content in spinalcord tissue
Seventy-two hours after SCI, reactive oxygen species (ROS) production in spinal
cord samples was measured by the oxidative fluorescent dye dihydroethidine
(DHE). About 10 µm of spinal cord frozen section were washed with PBS at 37 °C
for half an hour, then incubated with DHE for another half hour at 37 °C. The
oxidized DHE was measured via fluorescence microscopy. Seventy-two hours after
SCI, 1 cm of spinal cord tissue was taken with the injured segment as the
center. After tissue homogenization, we detected Malondialdehyde (MDA) content
(nmol/mg), as per kit instructions.
Flow cytometry
The spinal cord of the rats in each group was cut and digested into single-cell
suspensions by trypsin. After washing with PBS for 3 times, the cell density was
adjusted to 5×105 cells/mL. The cells were incubated with Annexin V
and PI, lasting 30 min at 4 °C, in the dark. Subsequent to the incubation, we
washed the cells with PBS for 3 times, adjusted the cell density to
106 cells/mL for detection with flow cytometry (C6), and used
CFlow Plus software for data analysis.
RT-qPCR
The spinal cord tissue was ground into powder with liquid nitrogen, and an
appropriate amount of TRlzon lysis solution (CW0580S; CWBIO) was added. After
that, the powder was converted into a liquid state to extract total RNA. We
measured the concentration and purity of RNA (OD260/OD280) with UV-Vis
spectrophotometer. The RNA was synthesized by reverse transcription, by applying
the HiFiScript cDNA first-strand synthesis kit (CW2569M; CWBIO). We used
fluorescent PCR instrument (CFX Connect™ real-time; Bio-Rad Laboratories) for
performing RT-qPCR. The reaction system was: RNase Free dH2O 9.5 µL; cDNA 1 µL;
upstream primer 1 µL; downstream primer 1 µL; and 2×qPCR mixture 12.5 µL. The
reaction steps were: pre-denaturation 95 °C, 10 min; denaturation 95 °C,10 s;
annealing 58 °C, 30 s; extension 72 °C, 30 s; 40 cycles. The primer sequences
are listed in Table 1 (synthesized by General Biosystems [Anhui] Co., Ltd.),
using β-actin as internal reference. The relative expression of TGF-β1, Smad3,
and Smad2 were calculated as per 2-△△Ct method.
Western blot
We cut 50 mg of sample and put it into a centrifuge tube. Then, it was added 1 mL
of RIPA cell lysate (C1053; APPLYGEN). Afterwards, we ground it thoroughly in a
grinder (65HZ, 60s) to a homogenate; centrifuged it at 12.000 rpm, lasting 15
min; and carefully aspirated the supernatant, to obtain the total protein. We
assayed the protein concentration as per BCA Protein Assay Kit (CW0014S; CWBIO).
Subsequently, the protein was denatured, loaded, and subjected to SDS-PAGE,
lasting 2 h. Then, it was transferred to the PVDF Membrane (IPVH00010;
Millipore), with a constant current of 300 mA, lasting 80 min. We incubated the
membrane with primary antibodies—anti-TGF-β1 (bs-0068R, Bioss, 1/500),
anti-Smad2 (AF6449, Affinity, 1/1000), anti-Smad3 (ab40854, Abcam, 1/1000), and
anti-GAPDH (TA-08, ZSGB-Bio, 1/2000)—overnight at 4 °C; then with HRP-labeled
secondary antibodies—HRP-labeled goat anti-mouse IgG (H+L) (ZB-2305, ZSGB-Bio,
1/2000), HRP-labeled goat anti-rabbit IgG (H+L) (ZB-2301, ZSGB-Bio, 1/2000)—,
lasting 2 h, at indoor temperature. ECL luminescent liquid (RJ239676; Thermo
Fisher Scientific) was dropped onto the membrane and exposed in a gel imaging
system. Ultimately, we used Quantityone software for analyzing the gray value of
each antibody band.
Statistical analysis
All data were statistically analyzed with Graphpad Prism7 and expressed as mean ±
SD. The inter-group significant differences were analyzed via T-test, one-way
and two-way ANOVA, and *p < 0.05.
Results
Motor function scores
The motor function scores of the five groups at different times after surgery are
provided in Table 1. BBB scores of the
model group at different time points were strikingly lower than those of the
control group (p < 0.05). Besides, in comparison to the model group, the BBB
scores of the MH group increased to a certain extent, and the ones of the
MH+Rutin group increased more than those of the MH group (p < 0.05). The BBB
scores of MH+Rutin group increased significantly at 30 days (p < 0.05).
Table 1
Primer sequences of TGF-β1, Smad3, Smad2, and β-actin.
Primer
Sequence
TGF-β1 F
GCTGAACCAAGGAGACGGAA
TGF-β1 R
GAAGTTGGCATGGTAGCCCT
Smad3 F
GCACACAATAACTTGGACCTACA
Smad3 R
CAGTTGGGAGACTGGACGAA
Smad2 F
TGAACTGTCTCCTACCACTCTCT
Smad2 R
CACTCCCCTTCCTATATGCCTTCTG
β-actin F
GCCATGTACGTAGCCATCCA
β-actin R
GAACCGCTCATTGCCGATAG
Pathological alterations of spinal cord tissue
The spinal cord of the five groups, 7 days after surgery, is shown in Fig. 1. The spinal cords of the control and
sham groups were more uniform, and their surfaces were smooth; whereas, in the
model, MH, and MH+Rutin groups, the morphology of the spinal cords has changed
to a certain extent, and the size of the front and back sides was different. It
can be seen, under high power microscope by HE staining, that the structure of
the spinal cord tissue in the control and sham groups was clear, without obvious
cavities and hemorrhage. Also, no inflammatory cell infiltration was observed in
the tissue, and the nerve cells were normal in shape and neatly arranged. In the
spinal cord injury (SCI) model group, massive hemorrhage, cell swelling, cell
vacuolar degeneration, partial nucleus shrinkage, disordered arrangement, and a
large number of inflammatory cell infiltration occurred. After MH and MH+Rutin
treatment, cell vacuolar degeneration was reduced, the morphology of nerve cells
was effectively restored, the arrangement was relatively complete, and the
inflammation infiltration was reduced (Fig.
2).
Figure 1
Spinal cord of each group 7 days after surgery. MH: mild hypothermia;
MH+Rutin: mild hypothermia plus rutin.
Figure 2
HE staining to observe the pathological changes of spinal cord. MH:
mild hypothermia; MH+Rutin: mild hypothermia plus rutin.
Influence of MH+Rutin on inflammatory response in SCI
For inquiring into the changes of inflammatory response during the treatment of
SCI with MH+Rutin, our personnel used ELISA for examining inflammatory factor
(TNF-a, IL-1β, and IL-8) and MPO contents. As a result, TNF-a content was
sensibly higher in the sham and model groups than in the control group (p <
0.01), whereas MH and MH+Rutin plainly minified TNF-a content (p < 0.01).
Furthermore, IL-1β and IL-8 contents did not alter dramatically in the five
groups. Additionally, MPO content was patently lower in the sham group than in
the control one (p < 0.01). Compared with the model group, MH and MH+Rutin
augmented MPO content (p > 0.05) (Fig.
3).
Figure 3
ELISA to detect TNF-a, IL-1β, IL-8, and MPO contents. **p < 0.01
vs. control group; ##p < 0.01 vs. model
group; MH: mild hypothermia; MH+Rutin: mild hypothermia
plus rutin.
Influence of MH+Rutin on oxidative stress in SCI
For exploring the changes of oxidative stress during the treatment of SCI with
MH+Rutin, we examined ROS and MDA contents in spinal cord tissue, respectively.
ROS content in the model group was significantly higher than in the sham and
control groups (p < 0.01), whereas MH and MH+Rutin dramatically dwindled ROS
content (p < 0.01) (Fig. 4). MDA
content was perspicuously higher in the model group than in the sham and control
groups (p < 0.01), whilst MH and MH+Rutin conspicuously diminished MDA
content (p < 0.05) (Fig. 5).
Figure 4
Relative ROS expression in rat spinal cord tissue.**p < 0.01
vs. control group; #p < 0.05 and ##p < 0.01 vs.
model group; MH: mild hypothermia; MH+Rutin: mild
hypothermia plus rutin.
Figure 5
ELISA to detect TNF-a, IL-1β, IL-8, and MPO contents. **p < 0.01
vs. control group; #p < 0.05 vs. model group; MH:
mild hypothermia; MH+Rutin: mild hypothermia plus rutin.
Influence of MH+Rutin on apoptosis after SCI
To probe whether MH+Rutin would or not affect cell apoptosis after SCI, we used
flow cytometry for testing spinal cord cell apoptosis. Consequently, the
apoptosis rates in the control and sham groups were 0.7% ± 0.3%, and 0.6% ±
0.4%, respectively. In another hand, the rate in the model group was 7.1% ±
1.3%; and, in MH and MH+Rutin groups, 6.1% ± 0.8% and 5.6% ± 0.7%, respectively,
which were rates perspicuously lower than those of the model group (p < 0.05)
(Fig. 6). The aforementioned results
revealed that MH+Rutin can repress cell apoptosis after SCI.
Figure 6
Flow cytometry to detect apoptosis. MH: mild hypothermia; MH+Rutin:
mild hypothermia plus rutin.
Influence of MH+Rutin on TGF-β/Smad pathway in SCI
To inquire whether the TGF-β/Smad pathway was involved or not in the treatment of
SCI with MH+Rutin, we adopted RT-qPCR and Western blot for assaying the mRNA and
protein expression levels of pathway related molecules (TGF-β1, Smad2, and
Smad3). RT-qPCR revealed that in comparison with the control group, TGF-β1 mRNA
level in the model group was saliently augmented (p < 0.01), whereas MH
noticeably diminished TGF-β1 expression (p < 0.01). In contrast to the model
group, MH and MH+Rutin strikingly diminished Smad2 mRNA level (p < 0.01).
Besides, Smad3 mRNA level was significantly lower in model group than in the
control one(p < 0.01). MH significantly augmented Smad3 expression(p <
0.01) (Fig. 7a). Western blot uncovered
that, in comparison to the control group, TGF-β1, Smad2, and Smad3 protein
levels in the model group were plainly increased(p < 0.01), and MH and
MH+Rutin could significantly reduce TGF-β1, Smad2, and Smad3 protein levels(p
< 0.01) (Figs. 7b and c). Those results evinced that MH+Rutin can
suppress the activation of TGF-β/Smad pathway, thereby restraining the cellular
inflammatory response after SCI.
Figure 7
RT-qPCR and Western blot to detect the expression of TGF-beta/Smad
pathway related molecules. (a) RT-qPCR to assay TGF-β1,
Smad2, and Smad3 gene expression; (b–c) Western blot to
assay TGF-β1, Smad2, and Smad3 protein expression. **p < 0.01
vs. control group; ##p < 0.01 vs.
model group; MH: mild hypothermia; MH+Rutin: mild
hypothermia plus rutin.
Discussion
In recent years, mild hypothermia has been considered a weighty method of
neuroprotection. It can improve the function of the cerebral cortex; inhibit
cerebral oxygen metabolism12; protect the
blood-brain barrier13; inhibit the
excessive release of neurotransmitters12,
inflammatory response, and calcium overload14; as well as accelerate the growth of nerve cell trunk; and
inhibit neuronal apoptosis15, thereby
alleviating and improving nervous system damage16. Zhang et al.4 have uncovered that hypothermia treatment can effectively reduce
the increase of extracellular ascorbic acid concentration caused by acute SCI,
thus reducing secondary SCI, and promoting spinal cord repair. In this study,
after treating SCI with mild hypothermia, the structure and morphology of the
rat spinal cord tissues were effectively protected, the arrangement was
relatively complete, and the inflammatory infiltration was reduced. In addition,
TNF-a content was significantly reduced; MPO content was partially increased;
and ROS and MDA content decreased. The aforementioned implied that mild
hypothermia may mitigate nervous system damage by reducing inflammation and
oxidative stress.Rutin, also known as rutinoside, is a glycoside composed of the flavonoidaglyconequercetin and the disacchariderutinose, and is a citrus flavonoidglycoside found in buckwheat. Rutin has been substantiated to have diverse
pharmacological activities, and serves as an antioxidant, as well as
cytoprotective, vasoprotective, anticancer, neuroprotective, and
cardioprotective agents18-20. Khan et al.21 have discovered that
ischemia-reperfusion injury, caused the production of free radicals, hence
posing nerve damage and taking rutin, can reduce p53 expression to prevent
morphological changes and increase the enzyme activity of endogenous
antioxidants to reduce ischemic nervous cell apoptosis. Wu et
al.22 have corroborated that
rutin can significantly reduce reactive oxygen species, malondialdehyde, NLRP3,
ASC, caspase-1, IL-1β, IL-18, and TNF-a levels in rat SCI models, as well as
attenuate histological changes and improve exercise recovery. In the present
study, MH+Rutin could increase the BBB score of rats; meliorate the structure of
spinal cord tissue; significantly reduce TNF-a content; increase MPO content;
and reduce ROS and MDA contents in the spinal cord, indicating that the
mechanism of rutin may be implicated in alleviating inflammation and oxidative
stress.The activation of microglia and the production of various cytokines after SCI
lead to increased inflammatory response and enhanced activation of the TGF-β and
Smad2 pathways23. The TGF-β/Smad pathway
contributes to scar formation, and plays a role in recovering after an injury,
but excessive formation of scar tissue affects functional recovery24. As a downstream signal of TGF-β, Smad2
seems to mediate scar gliosis by activating the intrinsic transcriptional
program of nerve cells. Hellal et al.25 used paclitaxel to inhibit kinesin-dependent Smad2
translocation and reduce the scar tissue around the lesion. In this study,
treating rat SCI with mild hypothermia significantly inhibited TGF-β1 and Smad2
gene expressions, while MH+Rutin had no significant effect on the expression of
TGF-β1. This indicates that rutin may inhibit the effect of mild hypothermia on
TGF-β1 gene expression, but has no effect on the expression of Smad2. On the
contrary, mild hypothermia up-regulated Smad3 gene expression, which rutin could
inhibit. At the protein level, the effects of MH+Rutin on TGF-β1 and Smad3
expressions were not significantly different from mild hypothermia, but they
exhibited a coordinated effect on Smad2 expression. It is possible that rutin
mainly acts by inhibiting this expression on Smad2, indicating that MH+Rutin may
inhibit the activation of TGF-β1 and Smad2 in the TGF-β/Smad pathway to inhibit
secondary injury after SCI.
Conclusion
Overall, MH+Rutin is available to inhibit the activation of TGF-β/Smad pathway,
thereby inhibiting the cellular inflammatory response after SCI.
Authors: Farida Hellal; Andres Hurtado; Jörg Ruschel; Kevin C Flynn; Claudia J Laskowski; Martina Umlauf; Lukas C Kapitein; Dinara Strikis; Vance Lemmon; John Bixby; Casper C Hoogenraad; Frank Bradke Journal: Science Date: 2011-01-27 Impact factor: 47.728
Authors: H Javed; M M Khan; A Ahmad; K Vaibhav; M E Ahmad; A Khan; M Ashafaq; F Islam; M S Siddiqui; M M Safhi; F Islam Journal: Neuroscience Date: 2012-03-06 Impact factor: 3.590